You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

10 February 2021

Less than 2% of pregnant women in Uganda receive timely viral load testing

Low rates of viral load testing among pregnant women highlight need to review care for pregnant women living with HIV.

05 February 2021

PrEP vaginal ring set for rollout after WHO endorsement

Significant step as WHO recommends the dapivirine vaginal ring as a new HIV prevention tool following promising trial results

15 December 2020

The link between vaginal bacteria and PrEP effectiveness

A study suggests vaginal bacteria may be playing an underestimated role in PrEP efficacy for women

09 December 2020

Voucher scheme to encourage young South African women to take PrEP has modest impact

Trial reports a 15% difference in high PrEP adherence among participants who received vouchers compared to those who didn’t – but this fell significantly after the vouchers stopped.

18 November 2020

Injectable PrEP tops list as the preferred choice for adolescent girls in Cape Town

UChoose study is the first to assesses adolescent girls’ preferences for contraceptives that mirror PrEP products to establish what type of PrEP is most likely to work for them

27 August 2020

PrEP use does not worsen mental health outcomes, finds Amsterdam study

Dutch study finds no evidence to suggest PrEP use increases mental health issues – and may actually help reduce sexual compulsivity and drug-misuse.

12 August 2020

Peer-based clubs may offer valuable PrEP initiation support to adolescent girls and young women

An evaluation of peer support clubs in settings with high HIV and gender-based violence prevalence finds increased self-esteem and self-efficacy among participants.

31 July 2020

‘Significant step’ for HIV prevention as vaginal ring gets green light from the European Medicines Agency

Ring containing the antiretroviral drug dapivirine could be available in Africa as early as 2021 after it was found to reduce women’s HIV risk by 30 to 50%.

06 March 2020

PrEP could avert up to 8% of new infections by 2030

Modelling finds PrEP has the potential to avert between 3 and 8% of HIV infections in 13 African and Caribbean countries by 2030 if three key populations can access it

07 February 2020

PrEP during pregnancy: safety evidence ‘reassuring’ but gaps remain

Research on PrEP safety for pregnant women and their babies finds no adverse effects – but knowledge gaps remain.